Method for stabilizing DNA aptamers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

TDNs-AS1411-nucleic acid drug nanocomposite based drug delivery system and preparation method thereof

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

Compositions with improved intravitreal half-life and uses thereof

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS

Methods of detecting a solid tumor with anti-IL1RAP antibodies

METHOD OF ISOLATING NUCLEIC ACID

EXOGENOUS CONTROL OF MAMMALIAN GENE EXPRESSION THROUGH APTAMER-MEDIATED MODULATION OF POLYADENYLATION

α-amylase-binding nucleic acid molecule and use thereof

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Aptamers for mycotoxin detoxification

Portable nanoaptamer analyzer for detection of bisphenol A

Single-cell proteomic assay using aptamers

Functional tRNA-aptamer molecules

Quencher containing water soluble polymer-conjugated nanomaterial and use thereof

DNA aptamer that binds to vWF

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH17 MEDIATED DISEASES

ESCHERICHIA COLI O157:H7 APTAMER AND APPLICATIONS THEREOF

Oligonucleotide inhibitor of DNA polymerases

Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers

Peptides and combination thereof for use in the immunotherapy against cancers

Aptamers for the treatment of sickle cell disease

Aptasensor and method of detecting target material

LIN28- MEDIATED CONTROL OF LET-7 BIOGENESIS

FLUORESCENT BIOSENSOR FOR METHYLTRANSFERASE ASSAY

Method of synthesis and purification of a nucleoside and/or a nucleotide, a modified nucleoside and/or nucleotide, a DNA molecule and an oligonucleotide library comprising said modified nucleoside and/or nucleotide and the use of said oligonucleotide library

PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disorders

Antagonistic PDL1 aptamers and their applications in cancer therapy

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Targeting microRNAs for metabolic disorders

HIGH-THROUGHPUT SPLIT APTAMER SCREENING ASSAY

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

Methods for detection of RNase activity

Method and kit for analyte detection

ANTIBODY OR ANTIBODY FRAGMENT OF NON-IG SCAFFOLD BINDING TO A BINDING REGION OF AN ANTI-N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTIBODY

Stabilization method of functional nucleic acid

Functional ligands to target molecules

Compositions and methods for regulation of gene expression with, and detection of, folinic acid and folates

METHODS OF SCREENING FOR RIBOSWITCHES AND ATTENUATORS

APTAMER-GUIDED GENE TARGETING

C5a binding nucleic acids

Molecular sensor selection

Reagents and methods for detecting infectious diseases

Oligonucleotide compositions and methods thereof

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF

METHOD FOR INDIVIDUALIZED CANCER THERAPY

Enzymatic synthesis of L-nucleic acids

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

Treatment of age-related macular degeneration and other eye diseases with apolipoprotein mimetics

Fluidic devices with freeze-thaw valves with ice-nucleating agents and related methods of operation and analysis

Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and MRI and/or X-ray contrast agents

2′ fluoro-modified RNAs as immunostimulators

Immunotherapy against melanoma and other cancers

Multiaptamer target detection

Inhibitors of DEK protein and related methods

Synthetic hammerhead ribozymes with ligand-responsive tertiary interactions

Compositions and methods for enrichment of cells

Modified L-Nucleic Acid

FUNCTIONAL LIGANDS TO OPIOIDS AND OPIOID METABOLITES

RNA hydrogels

Therapeutic oligonucleotides

AGTR1 aptamer-anticancer drug complex for cancer cell chemotherapy

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

SDF-1 Binding Nucleic Acids

Method for generating aptamers with improved off-rates

Chemoselective modification of a carrier protein with a strained alkyne-labeled cargo agent

Aptasensor for detecting female-specific trace of blood and detection apparatus using the same

Method of determining a protein in a sample

Aptamer specific to ovarian cancer and detection method for ovarian cancer

Aptamers against glioma cells

Nucleic acid complexes for screening barcoded compounds

Stabilized STAT3 decoy oligonucleotides and uses therefor

Nucleic acid aptamers to treat histone-induced disease states

Use of aptamers in therapy and/or diagnosis of autoimmune diseases

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

5-position modified pyrimidines and their use

Continuously expressed therapeutic RNAs for targeted protein binding and methods for their use

Cocaine aptamer and method for detecting cocaine using the same

In vitro selection of formaldehyde cross-linking aptamers

Thrombus imaging aptamers and methods of using same

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

LncRNA serves as a biomarker and therapeutic target

Cocaine aptamer and method for detecting cocaine using the same

Isatoic anhydride derivatives and applications thereof

Cocaine aptamer and method for detecting cocaine using the same

Method of packing polynucleotides

Bivalent siRNA chimeras and methods of use thereof

Functional ligands to chikungunya envelope proteins

RNA nanoparticles and method of use thereof

Anti-cancer RNA aptamers

INTRACELLULAR TRANSLATION OF CIRCULAR RNA

Cell-specific internalizing RNA aptamers against human CCR5 and uses therefore

DNA-based testing for environmental contamination

RNA-guided gene editing system and uses thereof

CD38 ligand-drug conjugates for targeted cancer therapy

CD117 ligand-drug conjugates for targeted cancer therapy

NOVEL EXPRESSION REGULATING RNA-MOLECULES AND USES THEREOF

MCP-1 binding nucleic acids

FUNCTIONAL LIGANDS TO THC

Nucleic acid aptamers binding to vascular endothelial growth factor receptors

OLIGONUCLEOTIDE PROBES AND USES THEREOF

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS

Methods for the diagnosis and treatment of Sjögren's syndrome

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

miRNA modulators of thermogenesis

Hepcidin antagonists for use in the treatment of inflammation

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

THERAPEUTICS AND METHODS OF TREATING FATTY LIVER DISEASE

Methods and pharmaceutical compositions for the treatment of filovirus infections

Compositions and methods for inhibiting Factor D

HER2 aptamer-anticancer drug complex for cancer cell chemotherapy

HER2 aptamer-anticancer drug complex for cancer cell chemotherapy

Nucleic acid aptamer specifically binding to avian influenza virus subtype H5 and method of detecting avian ifluenza virus subtype H5 using the same

Structure assisted directed evolution of multivalent aptamers

TISSUE SPECIFIC MARKERS FOR PREOPERATIVE AND INTRAOPERATIVE LOCALIZATION AND VISUALIZATION OF TISSUE

EpCAM aptamers and conjugates thereof

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HIV INFECTION

Aptamers and sensing technology used for detection of glycated hemoglobin in whole blood

Use of aptamers in proteomics

FUNCTIONAL LIGANDS TO RICIN

APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS

Acyl-amino-LNA and/or hydrocarbyl-amino-LNA oligonucleotides

IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY

DNA APTAMER BINDING TO NON-SMALL CELL LUNG CANCER CELLS (H1975)

Nucleic acid compounds for binding growth differentiation factor 8

Regulation of gene expression by aptamer-mediated modulation of alternative splicing

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH ANGIOGENESIS USING A VASCULAR ADHESION PROTEIN-1 (VAP-1) INHIBITOR

Sialylated fetuin-A as a marker of immunotherapy efficacy

NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT

OLIGONUCLEOTIDE PROBES AND USES THEREOF

Factor V/Va-targeting aptamer compositions and methods of using the same

Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Method for detecting and quantifying biomaterials by using activity of nucleic acid polymerase regulated by target material

FLT3 receptor antagonists for the treatment or the prevention of pain disorders

Methods For Using Nucleic Acid Aptamers For Directed Templated Assembly

Methods for treating and/or limiting development of diabetes

Anti-IL-6 vaccine composition

Aptamers and diagnostic methods for detecting the EGF receptor

Decoy oligonucleotides for the treatment of diseases

Method for preventing spontaneous oxidation of antioxidant using aptamer, aptamer-based control of the release rate of active ingredient in the hydrogel, material and use thereof

A METHOD FOR PROGNOSIS OF OVARIAN CANCER, PATIENT'S STRATIFICATION

Factor XIa-specific aptamers

DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS

METHODS FOR DIAGNOSING AND TREATING CD1D RESTRICTED GAMMA/DELTA T CELL LYMPHOMAS

Methods and Pharmaceutical Compositions Using Orexins (OXA, OXB) for the Treatment of Prostate Cancers

Assay reagents for a neurogranin diagnostic kit

Polypeptides for the Treatment of Angiogenesis or Lymphangiogenesis-Related Diseases

RNA-targeting system

Immunotherapy against melanoma and other cancers

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

PHARMACEUTICAL COMPOSITION FOR TREATING A VIRAL INFECTION

Binding and catalytic molecules built from L-DNA with added nucleotides

METHOD OF IDENTIFYING OR PRODUCING AN APTAMER

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

Compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides

Aptamer capable of binding to HGF receptor

Methods and compositions for the treatment of cancer

Detecting residual host cell proteins in recombinant protein preparations

PRECIPITATION OF POLYPEPTIDES BY APTAMER-POLYMER CONJUGATES

Peptides and combination of peptides for use in immunotherapy against cancers

Post-selec modification methods

Aptamers for purifying and quantifying gelsolin and its variants

Uterine cancer treatments

APTAMER-RNAi THERAPEUTIC COMPOSITIONS

RAPID OLIGO PROBES

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

PDGF and VEGF aptamers having improved stability and their use in treating PDGF and VEGF mediated diseases and disorders

Compositions comprising an internalizing nucleic acid molecule, and their methods of use

VITAMIN K EPOXIDE RECYCLING POLYPEPTIDE VKORC1, A THERAPEUTIC TARGET OF COUMARIN AND THEIR DERIVATIVES

PDGFR RNA aptamers

DNA aptamers against cancer and uses thereof in delivery of therapy and diagnosis of cancer

Functional ligands to nerve agent metabolites

Means and Methods for the Treatment of Nephropathy

Method for affinity purification

RNA aptamers against transferrin receptor (TFR)

PREVENTION OF TUMOUR METASTASIS BY INHIBITION OF NECROPTOSIS

APTAMERS FOR USE AGAINST AUTOANTIBODY-ASSOCIATED DISEASES

Nucleic acid aptamers

APTAMERS FOR BINDING FLAVIVIRUS PROTEINS

LSPR-based high sensitivity aptamer sensor using intercalation agent

Antagonistic PD-1 aptamer and its applications in cancer therapy related applications

Targeting microRNAs for metabolic disorders

Nucleic acid amphiphiles and nanostructures

Antagonistic CTLA-4 aptamers and applications thereof in enhancing immune activity

T7 RNA polymerase variants with expanded substrate range and enhanced transcriptional yield

Treatment and prevention of malaria

ENCAPSULATION AND HIGH LOADING EFFICIENCY OF PHOSPHORYLATED DRUG AND IMAGING AGENTS IN NANOPARTICLES

Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof

FUNCTIONAL LIGANDS TO RICIN

NUCLEIC ACIDS ACTING AS DECOYS FOR THE TREATMENT OF LENTIVIRUS INFECTION

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

Aptamer targeting MAGE-A3 peptide and uses thereof

RNA APTAMER AND SENSOR EMPLOYING SAME

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

Nucleic acid compounds for binding to complement component 3 protein

APTAMERS FOR TOPICAL DELIVERY

Methods for the treatment of cardiovascular fibrosis

APTAMERS FOR TUMOR INITIATING CELLS

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

COMPOSITION OF ALLERGEN EXTRACTS HAVING REDUCED TOXICITY AND METHOD OF PRODUCTION THEREOF

Methods of treating fragile X syndrome and related disorders

Method for Production of Single-Stranded Macronucleotides

Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular Disorders

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

Method for Generating Aptamers with Improved Off-Rates

APTAMER INHIBITING BIOLOGICAL ACTIVITY OF AUTOTAXIN BY BINDING WITH AUTOTAXIN, AND USE THEREOF

STAT5 inhibitors and use thereof

Linker molecule for multiplex recognition by atomic force microscopy (AFM)

NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

Binding detection using liquid crystal

Aptamers specific for TLR-4 and uses thereof

Aptamers against EGFR and therapeutic uses thereof

Modified oligonucleotides for telomerase inhibition

Method of isolating aptamers for minimal residual disease detection

Specific oligonucleotide aptamer for the identification of T-2 toxin

Optimization method of a polynucleotide sequence

Aptamers with binding affinity to norovirus

Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2

Aptamer conjugates with N-heterocyclic carbene metal complexes for targeted drug delivery

Rapid in situ testing for environmental contamination

Oligonucleotide end caps

DNA NANOPARTICLE BASED CHECKPOINT INHIBITORS

DNA aptamers specific to CD200R1 and their therapeutic uses

Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

DNA aptamers for promoting remyelination

Method of treating a solid tumor with IL1RAP antibodies

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

CARBAPENEMASE AND ANTIBACTERIAL TREATMENT

ANTAGONISTS OF SLC38A9 AND THEIR USE IN THERAPY

Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy

Nucleic acid fragment binding to target protein

Binding-induced DNA nanomachines

Methods for preventing and treating chronic kidney disease (CKD)

Method of determining a protein in a sample

Methods for Prediction of Clinical Response to Radiation Therapy in Cancer Patients

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

Method for treating cancer with activated T cells

FUNCTIONAL LIGANDS TO TARGET MOLECULES AND METHODS

APTAMER FOR BONDING TO AUTOTAXIN AND INHIBITING BIOLOGICAL ACTIVITY OF AUTOTAXIN, AND USE FOR SAME

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

Assay reagents for a neurogranin diagnostic kit

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Method for treating cancer with an activated T lymphocyte that selectively recognizes a cancer cell consisting of specific peptide

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS

Isatoic anhydride derivatives and applications thereof

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Pincers comprising antibody and aptamer conjugated via a linker which binds to the same target material and use thereof

Pharmaceutical compositions for high-capacity targeted delivery

Biomarkers and Therapeutic Targets for Sarcoma

FUNCTIONAL LIGANDS TO TARGET MOLECULES

Method for treatment of heart failure

MiRNA modulators of thermogenesis

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

PEPTIDE APTAMERS FOR MANIPULATING PROTEIN FUNCTION

Modified L-Nucleic Acid

CHEMICALLY MODIFIED POLYNUCLEOTIDES AND METHOD FOR PRODUCING CHEMICALLY MODIFIED POLYNUCLEOTIDES

Adeno-associated virus virions with variant capsid and methods of use thereof

Adeno-associated virus virions with variant capsid and methods of use thereof

TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

Triptolide derivatives and preparation method and use thereof